comprehensive -WSS

comprehensive

author：entertainment 2025-09-28 02:31:27 - browse：6895

A view of different flags of the European Union Members. -- first opinion coverage from STAT — Ronald Wittek, Pool Photo via AP

Today, the criteria used to assess the clinical value of new pharmaceuticals and medical devices varies widely across Europe, making it more challenging for biopharma companies to efficiently launch products in multiple countries and contributing to the disparities in access across the continent.

But change is on the horizon: In less than 15 months, the European Union will establish and begin to implement a standardized, pan-EU framework, which all 27 of member states will be required to use to assess the clinical evidence of newly submitted products or devices. A key pillar of the EU’s Regulation on Health Technology Assessment (HTA), the Joint Clinical Assessment (JCA) aims to establish a single, transparent process to reduce redundant practices and bring life science innovation faster to patients in Europe — no matter where they live.

In a longstanding problem in Europe, access to — and the availability of — medication varies across the member states. For example, in Germany, 87% of products approved by the European Medicines Agency (EMA) have full availability (the product gained access on the public reimbursement list without any restrictions to the patient population). In Poland, that figure drops to 8%, according to a report published by the European Federation of Pharmaceutical Industries. Meanwhile, there is a tremendous difference in the gap between an oncology therapy receiving marketing authorization and a formal positive reimbursement decision, ranging from an average of 86 days in Denmark to 981 days in Latvia.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Inequities make cancer less preventable for women: report

explore

WSS

Researchers use wearables data and AI to predict preterm birth risk

Humana sues Biden admin over Medicare Advantage audit rule

What American doctors can learn from their Israeli counterparts

FDA advisers vote against ALS treatment from BrainStorm

Advances in CAR

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

focus

comprehensive

leisure time

What does generative AI mean for health care? We asked experts

What American doctors can learn from their Israeli counterparts

Walensky prepares to leave CDC — and Congress — behind

Ionis has late

State Dept. review finds Biden bears some blame for Afghanistan failures

WHO recommends dropping component of many flu vaccines

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Ionis has late

Guidelines to prevent youth baseball injuries need more muscle

After a drawn out lobbying fight, ARPA

focus

Medicaid rebukes states for mistakenly disenrolling children

Listen: Biogen's potential pivot, & Illumina's next chapter

Kaiser Permanente unions announce official strike date

Trump surgeon general acknowledges mistakes during Covid

Mindstrong's demise and the future of mental health care

STAT Virtual Event: How to Increase Diversity in Clinical Trials

focus

focus

explore

Wikipedia